Basic immunologic data of P1 and P2 are given with age-matched reference values
| . | P1 . | P2 . | |
|---|---|---|---|
| . | 5 mo . | 14 mo . | 15 mo . |
| CD3+ T cells (cells/µL) | 1095 (2300-6500) | 47 456 (1900-5900) | 8308 (1900-5900) |
| CD4+ (cells/µL) | 597 (1500-5000) | 12 022 (1400-4300) | 2536 (1400-4300) |
| CD8+ (cells/µL) | 498 (500-1600) | 30 372 (500-1700) | 4776 (500-1700) |
| CD19+ B cells (cells/µL) | 26 (600-3000) | 689 (600-2600) | 704 (610-2600) |
| CD16+/CD56+ NK cells (cells/µL) | 49 (100-1300) | 1094 (160-920) | 377 (160-920) |
| CD4+/CD45RA+ (%) | 89 (64-95) | 14 (63-91) | 84 (63-91) |
| CD3+/HLADR+ (%) | 16 (5-8) | 80 (5-8) | 13 (5-8) |
| . | P1 . | P2 . | |
|---|---|---|---|
| . | 5 mo . | 14 mo . | 15 mo . |
| CD3+ T cells (cells/µL) | 1095 (2300-6500) | 47 456 (1900-5900) | 8308 (1900-5900) |
| CD4+ (cells/µL) | 597 (1500-5000) | 12 022 (1400-4300) | 2536 (1400-4300) |
| CD8+ (cells/µL) | 498 (500-1600) | 30 372 (500-1700) | 4776 (500-1700) |
| CD19+ B cells (cells/µL) | 26 (600-3000) | 689 (600-2600) | 704 (610-2600) |
| CD16+/CD56+ NK cells (cells/µL) | 49 (100-1300) | 1094 (160-920) | 377 (160-920) |
| CD4+/CD45RA+ (%) | 89 (64-95) | 14 (63-91) | 84 (63-91) |
| CD3+/HLADR+ (%) | 16 (5-8) | 80 (5-8) | 13 (5-8) |
NK, natural killer cells.